Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said Tuesday in its quarterly report. Merck, which is facing plummeting sales of ...

For many Americans, pharmaceutical drugs are too expensive—and thanks to a system of complex and tedious bureaucracy, any effort for meaningful reform has been futile. Cost Plus Drugs wants to change ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

Additionally, Ro was the fifth-most seen brand during the 2025 World Series, with three separate spots — including its Serena Williams-led GLP-1 ad.

Key opportunities in the U.S. pharmaceutical market include growth in specialty drugs and personalized medicine, driven by ...

Skyrocketing healthcare costs could deliver another blow to the industry’s ongoing quest to boost representation in R&D.